IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
A quick look at the essentials of patent prosecution in Brazil, including key disclosure requirements for patent applications, expedited procedures, oppositions, timeframes and costs.
This article reviews the essential regulatory considerations surrounding medicines and medical devices in Brazil, including clinical trials and marketing authorisations.
The Brazilian Patent and Trademark Office published on November 2, 2021, its decision to accept good faith prior use allegations as grounds for administrative nullity proceedings.